account_balance
Investment manager · 13F filer · SEC CIK 1799883
5AM Venture Management, LLC
Reported value$288Mas of Jun 30, 2026
Positions16 0 new, 4 sold out
Top 10 weight85.6%MPLT alone is 12%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
MPLTMaplight Therapeutics Inc
11.8%
TYRATyra Biosciences Inc
11.4%
TRDAEntrada Therapeutics Inc
10.4%
PHVSPharvaris N V
9.6%
CAMPCamp4 Therapeutics Corp
8.9%
ARTVArtiva Biotherapeutics Inc
7.9%
TECXTectonic Therapeutic Inc
7.2%
ZNTLZentalis Pharmaceuticals Inc
6.7%
CLDXCelldex Therapeutics Inc New
6.4%
EYPTEyepoint Inc
5.2%
BHVNBiohaven Ltd
3.8%
SRZNSurrozen Inc
2.4%Trimmed −30%
MPLTMaplight Therapeutics Inc
11.8%
TYRATyra Biosciences Inc
11.4%
TRDAEntrada Therapeutics Inc
10.4%
PHVSPharvaris N V
9.6%
CAMPCamp4 Therapeutics Corp
8.9%
ARTV7.9%TECX7.2%ZNTL6.7%CLDX6.4%EYPT5.2%BHVN3.8%SRZNBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
MPLT Maplight Therapeutics Inc 11.8% HeldTYRA Tyra Biosciences Inc 11.4% HeldTRDA Entrada Therapeutics Inc 10.4% HeldPHVS Pharvaris N V 9.6% HeldCAMP Camp4 Therapeutics Corp 8.9% HeldARTV Artiva Biotherapeutics Inc 7.9% HeldTECX Tectonic Therapeutic Inc 7.2% HeldZNTL Zentalis Pharmaceuticals Inc 6.7% HeldCLDX Celldex Therapeutics Inc New 6.4% HeldEYPT Eyepoint Inc 5.2% HeldBHVN Biohaven Ltd 3.8% HeldSRZN Surrozen Inc 2.4% Trimmed −30%
What changed